Psychosocial Factors and Quality of Life in the Effect of Fear of COVID-19 With Cystic Fibrosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cystic Fibrosis
- Sponsor
- Elif Kabasakal
- Enrollment
- 128
- Locations
- 1
- Primary Endpoint
- fear of covid-19
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
The purpose of this study; The COVID-19 pandemic is to investigate the effects of COVID-19 fear levels of patients with cystic fibrosis on the psychosocial and quality of life levels of individuals.
Detailed Description
After individuals were informed about the study, it was administered to individuals who gave written informed consent.This study was carried out on individuals with cystic fibrosis and healthy individuals who meet the eligibility requirements, through online forms.
Investigators
Elif Kabasakal
ekabasakal
Medipol University
Eligibility Criteria
Inclusion Criteria
- •be 16 years of age or older
- •Having been diagnosed with Cystic Fibrosis
- •Volunteering to participate in the research
Exclusion Criteria
- •Being mentally incapable of successfully applying the scales to be applied for evaluation purposes
- •Being treated with sedative and antiepileptic drugs
- •Pregnancy
Outcomes
Primary Outcomes
fear of covid-19
Time Frame: November- December/2021
COVID-19 Fear Scale: This scale is a one-dimensional instrument consisting of seven items with robust psychometric properties that measure fear of COVID-19. It has a 5-point Likert-type rating system (1: Strongly disagree, 5: Strongly agree). It is reliable and valid in assessing fear of COVID-19 among the general population. Turkish validity and reliability of the scale were ensured.
Secondary Outcomes
- psychosocial factors(November-December/2021November-December/2021)